about
Novel interaction between the M4 muscarinic acetylcholine receptor and elongation factor 1A2Libidibia ferrea mature seeds promote antinociceptive effect by peripheral and central pathway: possible involvement of opioid and cholinergic receptors.Serotonin receptors are involved in the spinal mediation of descending facilitation of surgical incision-induced increase of Fos-like immunoreactivity in rats.In search of analgesia: emerging roles of GPCRs in pain.Spinal alpha 2-adrenoceptor-mediated analgesia in neuropathic pain reflects brain-derived nerve growth factor and changes in spinal cholinergic neuronal functionA tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the anti-hypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury.Cholinergic mechanisms in spinal locomotion-potential target for rehabilitation approaches.Optimal single-dose epidural neostigmine for postoperative analgesia after partial hepatectomySpinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.Depletion of endogenous noradrenaline does not prevent spinal cord plasticity following peripheral nerve injuryInvolvement of hippocampal acetylcholinergic receptors in electroacupuncture analgesia in neuropathic pain rats.Multiplicative interactions to enhance gabapentin to treat neuropathic pain.Morphine increases acetylcholine release in the trigeminal nuclear complexInvolvement of spinal muscarinic and serotonergic receptors in the anti-allodynic effect of electroacupuncture in rats with oxaliplatin-induced neuropathic pain.Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats.The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example.Mechanisms of electroacupuncture-induced analgesia on neuropathic pain in animal model.Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats.Electroacupuncture at 2/100 hz activates antinociceptive spinal mechanisms different from those activated by electroacupuncture at 2 and 100 hz in responder rats.The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy.Neostigmine interactions with non steroidal anti-inflammatory drugs.Intravenously administered oxotremorine and atropine, in doses known to affect pain threshold, affect the intraspinal release of acetylcholine in rats.Carbachol interactions with nonsteroidal anti-inflammatory drugs.The effects of the alpha2-adrenergic receptor agonists clonidine and rilmenidine, and antagonists yohimbine and efaroxan, on the spinal cholinergic receptor system in the rat.Analgesic effect of electroacupuncture on inflammatory pain in collagen-induced arthritis rats: mediation by alpha2- and beta-adrenoceptors.The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed.Upregulation of the high-affinity choline transporter in colon relieves stress-induced hyperalgesiaM2 Receptors Exert Analgesic Action on DRG Sensory Neurons by Negatively Modulating VR1 Activity
P2860
Q28202533-29197FA4-BD71-44F8-A096-BC63DB881B65Q33594431-1B251885-48FA-404B-A5AE-8E1D68BF2F93Q33813371-02182315-243F-45C8-A5F2-E0803973E31FQ33819256-E88D8599-71F5-4510-B6F0-D17BCA0834D9Q34073873-D0724DE7-07F4-4164-B777-D7200558E3DDQ34336156-18AD23AA-4190-4EB8-A576-48D424C285BBQ34462587-3C3D07B7-F42C-4ED2-8943-20910724FED7Q34684604-535E3F3D-5BBE-4E37-A13B-8D8EFAE5074EQ35100897-8A4550EF-8C8B-4BA8-96A2-ED1DF37141FFQ36054707-A572BEDA-02EE-4140-AED7-8C8AC6BFFF5CQ36790453-57B50C3D-2441-4C47-AC1C-64B441D143FDQ36972856-0D981A7E-6114-4CBE-85EE-4375FC93DA60Q37016513-B477D891-4670-413F-BFC2-AC844A1C9B33Q37060295-49EDBC78-736E-4613-8F59-5070DB8D2441Q37352880-6F1FEADB-20FB-44AA-AC58-83DF4D5EF5B5Q37722571-4709394C-F359-42B3-A82D-45062C5ADE48Q37872360-21AB22F1-CE8B-4729-B9B6-0A41B66CFFD3Q38132137-5CD3C4EF-9AF6-4521-8AA9-5C81C71CE41AQ39485738-A9D1FB3C-EF30-41EE-B273-5BDF030C3AD3Q41963053-E3CD4635-8A85-41F3-80C0-E15AE76B3B97Q43160872-F15F6849-EA19-420F-84DD-D9D7CAEFBE00Q43263827-F129AF09-02D3-46C5-92C3-9BF459D2F808Q44036375-055143A8-B3A3-4648-8164-AF8F687421EAQ44300921-7B524ECB-7175-4B8E-AB78-FFB167D41B2FQ44839898-21137023-FC5A-4670-8078-6D589858830CQ45330727-8D2DF1C4-A66B-46CE-99BA-8C015DAA4FAEQ50063290-2737719E-CF31-4606-B3E2-3CBA9ACE92A2Q57071290-B4516928-CE57-4E13-B2A4-44466120A7DBQ57245536-88DC30DA-2F4B-42CE-A3D2-1324A6A6E93F
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Muscarinic-mediated analgesia.
@ast
Muscarinic-mediated analgesia.
@en
Muscarinic-mediated analgesia.
@nl
type
label
Muscarinic-mediated analgesia.
@ast
Muscarinic-mediated analgesia.
@en
Muscarinic-mediated analgesia.
@nl
prefLabel
Muscarinic-mediated analgesia.
@ast
Muscarinic-mediated analgesia.
@en
Muscarinic-mediated analgesia.
@nl
P1433
P1476
Muscarinic-mediated analgesia.
@en
P2093
Eisenach JC
P304
P356
10.1016/S0024-3205(98)00600-6
P407
P577
1999-01-01T00:00:00Z